MED Medifast, Inc.

NYSE
$11.43

Medifast, Inc. (MED) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal Bullish Insiders bought more than they sold over this window — uncommon at any size.
Cluster activity 0 buyers in the last 30 days 1 buyer in the last 90 days 1 seller in the last 90 days
Insiders buying
2
10 transactions
Insiders selling
1
2 transactions
Purchases
$1.5M
124,966 shares
Sales
$226.3K
19,089 shares
Net activity
$1.3M
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $226.3K 2 transactions · 19,089 shares

Largest single sale: $114.3K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 26, 2026 , by Kiai Parsa .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Chard Daniel R Director Sell 9,544 $11.73 $112.0K 130,609 −6.8% of holding
Chard Daniel R Director Sell 9,545 $11.98 $114.3K 140,153 −6.4% of holding
Kiai Parsa 2 fills Director Buy 43,150 $12.26 $529.2K 707,492
Kiai Parsa 2 fills Director Buy 4,329 $12.00 $51.9K 665,517
Kiai Parsa 2 fills Director Buy 43,150 $11.60 $500.7K 661,306
Kiai Parsa 2 fills Director Buy 29,337 $11.66 $342.0K 619,331
SCHLACKMAN SCOTT Director Buy 2,500 $12.53 $31.3K 30,549
SCHLACKMAN SCOTT Director Buy 2,500 $12.65 $31.6K 28,049

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.